Atlas Trials

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Clinical trial NCT07018037 · RECRUITING

Trial details

NCT number
NCT07018037
Sponsor
Regina Elena Cancer Institute
Status
RECRUITING
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2025-01-29
Primary completion
2026-01-29
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.